Skip to main content
SpringerLink
Log in

C-Reactive Protein and Incident Left Ventricular Hypertrophy in Essential Hypertension

  • ORIGINAL ARTICLE
  • Published:
Pediatric Cardiology Aims and scope Submit manuscript

Abstract

Elevated C-reactive protein (CRP) levels have been associated with increased cardiovascular risk in hypertensive adults. The aim of this study was to determine whether plasma CRP level is more predictive of left ventricular hypertrophy (LVH) than is ambulatory blood pressure (BP) in hypertensive children. Baseline and 12-month follow-up measures of BP, body mass index (BMI), low-density lipoprotein/high density lipoprotein cholesterol, left ventricular mass (LVM), and CRP data collected from 48 newly diagnosed, untreated hypertensive children were analyzed. CRP was measured by a highly sensitive nephelometric method. Left ventricular mass index (LVMI) was calculated as LVM/height2.7, and LVH was defined as LVMI >38.6 g/m2.7 being the cut-point for the 95th percentile found in healthy children. Average systolic BP (SBP), diastolic BP (DBP), SBP index, and DBP index were calculated. All patients received hydrochlorothiazide therapy in combination with angiotensin converting enzyme inhibitor treatment. Five patients also had angiotensin receptor blocker therapy to reach the target BP (<95th percentile corrected for age and gender). In a multiple regression analysis, LMVI was correlated with CRP, BMI, SBP, and SBP index. CRP alone explained 77% of the variance of LVMI, whereas BMI, SBP, and SBP index explained only 1.3, 0.3, and 0.4% of the variance, respectively. CRP was also the most significant correlate of follow-up LVH. In conclusion, elevated CRP level is significantly associated with LVH in children with essential hypertension. BP reduction with renin–angiotensin system blocker and hydrochlorothiazide therapy reduces LVH while lowering CRP level.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Assadi F (2007) Effect of microalbuminuria-lowering on regression of left ventricular hypertrophy in children and adolescents with essential hypertension. Pediatr Cardiol 28:27–33

    Article  PubMed  Google Scholar 

  2. Asselbergs FW, Diercks FH, Hillege HL, et al. (2004) Effects of fosinopril and pravastatin on cardiovascular events in microalbuminuric subjects: Results of the PREVEND IT. Circulation 110:2809–2816

    Article  PubMed  CAS  Google Scholar 

  3. Blake GJ, Ridker PM (2003) C-reactive protein and other inflammatory risk markers in acute coronary syndromes. J Am Coll Cardiol 41:372

    Google Scholar 

  4. Brasier AR, Recinos A, Eledrisi MS (2002) Vascular inflammation and the renin–angiotensin system. Arterioscler Thromb Vasc Biol 22:1257–1266

    Article  PubMed  CAS  Google Scholar 

  5. Briars GL, Bailey BG (1994) Surface area estimation: Pocket calculator versus nomogram. Arch Dis Child 70:246–247

    Article  PubMed  CAS  Google Scholar 

  6. Daniels SR, Loggie JM, Khoury P, Kimball TR (1998) Left ventricular geometry and severe left ventricular hypertrophy in children and adolescents with essential hypertension. Circulation 97:1907–1911

    PubMed  CAS  Google Scholar 

  7. de Simone G, Daniels SR, Devereux RB, et al. (1992) Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 20:1251–1260

    Article  PubMed  Google Scholar 

  8. de Simone G, Devereux RB, Daniels SR, et al. (1995) Effect of growth on variability of left ventricular mass. Assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol 25:1056–1062

    Article  PubMed  Google Scholar 

  9. Devaraj S, Xu DY, Jialal I (2003) C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis. Circulation 107:398–404

    Article  PubMed  CAS  Google Scholar 

  10. Devereux RB, Alonso DR, Lutas EM, et al. (1986) Echocardiograph assessment of left ventricular hypertrophy: comparison to necroscopy findings. Am J Cardiol 75:450–458

    Article  Google Scholar 

  11. Herbert LA, Wilmer WA, Falkenhain ME, et al. (2001) Renoprotection: one or many therapies? Kidney Int 59:1211–1226

    Article  Google Scholar 

  12. Lande MB, Carson NL, Roy J, Meagher CC (2006) Effect of childhood primary hypertension on carotid initma media thickness: a matched controlled study. Hypertension 48:40–44

    Article  PubMed  CAS  Google Scholar 

  13. Litwin M, Niemirska A, Sladowska J, et al. (2006) Left ventricular hypertrophy and arterial wall thickening in children with essential hypertension. Pediatr Nephrol 21:811–819

    Article  PubMed  Google Scholar 

  14. Mattman A, Eintracht S, Mock T, et al. (2006) Estimating pediatric glomerular filtration rates in the era of chronic kidney disease staging. J Am Soc Nephrol 17:485–496

    Article  Google Scholar 

  15. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555–576

    Article  Google Scholar 

  16. Ogden CL, Kuczmarski RJ, Flegal KM, et al. (2002) Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 109:45–60

    Article  PubMed  Google Scholar 

  17. Pia Jk, Pischon T, Ma J, et al. (2004) Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 351:2599–2610

    Article  Google Scholar 

  18. Ramaswamy P, Lytrivi ID, Paul C, Golden M, Kupferman JC (2006) Regression of left ventricular hypertrophy in children with antihypertensive therapy. Pediatric Nephrol 22:141–143

    Article  Google Scholar 

  19. Ridker PM (2001) High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 103:1813–1818

    PubMed  CAS  Google Scholar 

  20. Ridker PM, Hennekens CH, Buring JE, Rifai N (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342:836–843

    Article  PubMed  CAS  Google Scholar 

  21. Rutter MK, Meigs JB, Sullivan LM, D’Agostina RB Sr, Wilson PW (2004) C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 110:380–385

    Article  PubMed  CAS  Google Scholar 

  22. Schillaci G, Pirro M, Gemelli F, et al. (2003) Increased C-reactive protein concentrations in never-treated hypertension: the role of systolic and pulse pressures. J Hypertens 21:1841–1846

    Article  PubMed  CAS  Google Scholar 

  23. Schwartz GJ, Haycock GB, Edelmann CM Jr, Spitzer A (1976) Predicting glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 106:522–526

    Google Scholar 

  24. Sorof JM, Cardwell G, Portman RJ (2002) Ambulatory blood pressure and left ventricular mass index in hypertensive children. Hypertension 39:903–908

    Article  PubMed  CAS  Google Scholar 

  25. Verma S, Li SH, Badiwala MV, et al. (2002) Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation 105:1890–1896

    Article  PubMed  CAS  Google Scholar 

  26. Verma S, Wang CH, Li SH, et al. (2002) A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 106:913–919

    Article  PubMed  CAS  Google Scholar 

  27. Viberti G, Wheeldon NM (2002) Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: a blood pressure independent effect. Circulation 106:672–678

    Article  PubMed  CAS  Google Scholar 

  28. Wang CH, Li SH, Weisel RD, et al. (2003) C-reactive protein upgrades angiotensin type 1 receptors in vascular smooth muscle. Circulation 107:1783–1790

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The author thanks John Bokowski for assistance in performing the two-dimensional directed M-mode echocardiography. The author is also grateful to the following people for their contribution to the study: Omid Rouhi, Ira Shetty, Barbara A. Santucci, Allen R. Wendt, Bridget L. Voigt, Beth A. Volin, Sara Verghese, Gary R. Strokosch, William B. Stratbucker, Rita M. Rossi-Foulkes, Jeffrey M. Mjaanes, Stephanie L. Luther, Jane E. Kramer, Karen R. Judy, Cathy Lynn A. Joyce, Cynthia M. Hoess, Erin A. Flanagan-Klygis, and Carrie L. Drazba.

Author information

Authors and Affiliations

  1. Department of Pediatrics, Section of Nephrology, Rush University Medical Center, 1725 West Harrison Street, Professional Building, Suite 710, Chicago, IL, 60612, USA

    Farahnak Assadi

Authors
  1. Farahnak Assadi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Farahnak Assadi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Assadi, F. C-Reactive Protein and Incident Left Ventricular Hypertrophy in Essential Hypertension. Pediatr Cardiol 28, 280–285 (2007). https://doi.org/10.1007/s00246-006-0173-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00246-006-0173-2

Keywords

Search

Navigation